Huang Chung-Ming, Sung Fung-Chang, Chen Hsuan-Ju, Lin Che-Chen, Lin Cheng-Li, Huang Po-Hao
Division of Immunology and Rheumatology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Graduate Institute of Integrated Medicine, China Medical University College of Chinese Medicine, Taichung, Taiwan.
Medicine (Baltimore). 2022 Jan 7;101(1):e28487. doi: 10.1097/MD.0000000000028487.
Studies on the thyroid disease risk in patients with rheumatoid arthritis (RA) associated with comorbidities are limited. This population-based retrospective cohort study investigated the hypothyroidism risk in patients with RA and the role of comorbidities.We used Taiwan National Health Insurance Research Database to identify 16,714 RA patients newly diagnosed in 2000 to 2008 and 66,856 control persons without RA, frequency matched by sex, age, and index year. Incidence and the RA group to controls hazard ratio of hypothyroidism were estimated.The hypothyroidism incidence was 1.74-fold higher in the RA group than in controls (16.6 vs 9.52 per 10,000 person-years), with the Cox method estimated adjusted hazard ratio of 1.67 (95% confidence interval = 1.39-2.00) after controlling for covariates. Near 75% of the study population were women, with the incidence 3.6-time higher than men in both groups. The hypothyroidism incidence increased with age, from 12.1 per 1000 person-years in 20 to 39 years to 20.0 per 1000 person-years in 60+ years in RA patients, higher than that in controls (7.17 vs 10.0 per 1000 person-years, respectively by age). Each comorbidity was related to an increased incidence and higher in the RA group than in controls. Among all comorbidities, stroke exerted the greatest impact in the RA group with an adjusted hazard ratio of 3.85 (95% confidence interval = 1.24-12.0).RA patients have an increased risk of developing hypothyroidism; this risk was pronounced in women and the elderly. RA patients should be closely monitored to prevent the development of hypothyroidism.
关于类风湿性关节炎(RA)合并症患者甲状腺疾病风险的研究有限。这项基于人群的回顾性队列研究调查了RA患者的甲状腺功能减退风险以及合并症的作用。我们使用台湾国民健康保险研究数据库,确定了2000年至2008年新诊断的16714例RA患者和66856例无RA的对照者,按性别、年龄和索引年份进行频率匹配。估计了甲状腺功能减退的发病率以及RA组与对照组的危险比。RA组甲状腺功能减退的发病率比对照组高1.74倍(每10000人年16.6例对9.52例),采用Cox方法在控制协变量后估计调整后的危险比为1.67(95%置信区间=1.39-2.00)。近75%的研究人群为女性,两组中女性的发病率均比男性高3.6倍。甲状腺功能减退的发病率随年龄增加而升高,RA患者从20至39岁时的每1000人年12.1例增至60岁以上时的每1000人年20.0例,高于对照组(按年龄分别为每1000人年7.17例对10.0例)。每种合并症都与发病率增加有关,且RA组高于对照组。在所有合并症中,中风对RA组的影响最大,调整后的危险比为3.85(95%置信区间=1.24-12.0)。RA患者发生甲状腺功能减退的风险增加;这种风险在女性和老年人中更为明显。应密切监测RA患者以预防甲状腺功能减退的发生。